Skandinaviska Enskilda Banken (SEB)
AMPH icon

Skandinaviska Enskilda Banken (SEB)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,000
Closed -$680K – 793
2023
Q4 		$680K Hold
11,000
– – ﹤0.01% 742
2023
Q3 		$506K Sell
11,000
-2,200
-17% -$120K ﹤0.01% 769
2023
Q2 		$759K Buy
+13,200
New +$585K 0.01% 736
2021
Q2 		– Sell
-36,800
Closed -$674K – 1045
2021
Q1 		$674K Hold
36,800
– – ﹤0.01% 890
2020
Q4 		$740K Sell
36,800
-23,600
-39% -$459K 0.01% 862
2020
Q3 		$1.13M Hold
60,400
– – 0.01% 708
2020
Q2 		$1.36M Sell
60,400
-37,900
-39% -$694K 0.01% 660
2020
Q1 		$1.46M Buy
98,300
+22,500
+30% +$391K 0.01% 563
2019
Q4 		$1.46M Sell
75,800
-18,400
-20% -$353K 0.01% 637
2019
Q3 		$1.87M Sell
94,200
-8,800
-9% -$183K 0.02% 563
2019
Q2 		$2.17M Sell
103,000
-14,200
-12% -$297K 0.02% 487
2019
Q1 		$2.39M Sell
117,200
-500
-0.4% -$11.2K 0.02% 425
2018
Q4 		$2.34M Sell
117,700
-34,600
-23% -$682K 0.02% 433
2018
Q3 		$2.93M Buy
152,300
+9,200
+6% +$164K 0.02% 407
2018
Q2 		$2.18M Buy
143,100
+18,800
+15% +$329K 0.02% 411
2018
Q1 		$2.33M Sell
124,300
-14,800
-11% -$278K 0.02% 367
2017
Q4 		$2.68M Sell
139,100
-33,900
-20% -$633K 0.02% 381
2017
Q3 		$3.09M Sell
173,000
-9,400
-5% -$155K 0.03% 376
2017
Q2 		$3.26M Sell
182,400
-34,200
-16% -$542K 0.03% 367
2017
Q1 		$3.14M Buy
216,600
+42,400
+24% +$667K 0.03% 364
2016
Q4 		$3.21M Sell
174,200
-40,400
-19% -$786K 0.04% 304
2016
Q3 		$4.07M Sell
214,600
-30,200
-12% -$548K 0.04% 296
2016
Q2 		$3.95M Hold
244,800
– – 0.04% 293
2016
Q1 		$2.94M Sell
244,800
-39,200
-14% -$462K 0.03% 334
2015
Q4 		$4.04M Buy
+284,000
New +$3.75M 0.05% 247

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s AMPH Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2024, closing a stake of 11,000 shares — an estimated $680K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in AMPH in Q4 2015 and held it in 25 quarters. The position peaked at $4.07M in Q3 2016. 271 funds tracked by Wall St. Rank hold AMPH as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Amphastar Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 11,000 Amphastar Pharmaceuticals shares in Q1 2024, an estimated $680K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Amphastar Pharmaceuticals in Q4 2015 and held it in 25 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Amphastar Pharmaceuticals position peaked at $4.07M in Q3 2016.
  • 271 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.